148 related articles for article (PubMed ID: 25149140)
1. Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma.
Chen B; Chen XP; Wu MS; Cui W; Zhong M
Eur J Med Res; 2014 Aug; 19(1):45. PubMed ID: 25149140
[TBL] [Abstract][Full Text] [Related]
2. Upstream Stimulatory Factors 1 and 2 activate the human hepatic lipase promoter via E-box dependent and independent mechanisms.
van Deursen D; van Leeuwen M; Vaulont S; Jansen H; Verhoeven AJ
Biochim Biophys Acta; 2009 Apr; 1791(4):229-37. PubMed ID: 19416648
[TBL] [Abstract][Full Text] [Related]
3. Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.
Huang GL; Li BK; Zhang MY; Wei RR; Yuan YF; Shi M; Chen XQ; Huang L; Zhang HZ; Liu W; Huang BJ; Li H; Zheng XF; Luo XR; Wang HY
PLoS One; 2012; 7(8):e44061. PubMed ID: 22952874
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells.
Chen XP; Luo JS; Tian Y; Nie CL; Cui W; Zhang WD
Biomed Res Int; 2015; 2015():241983. PubMed ID: 26839882
[TBL] [Abstract][Full Text] [Related]
5. Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.
van Deursen D; Jansen H; Verhoeven AJ
Diabetologia; 2008 Nov; 51(11):2078-87. PubMed ID: 18758746
[TBL] [Abstract][Full Text] [Related]
6. PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.
Liao BY; Wang Z; Hu J; Liu WF; Shen ZZ; Zhang X; Yu L; Fan J; Zhou J
Tumour Biol; 2016 Mar; 37(3):2987-98. PubMed ID: 26415733
[TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of follicle-stimulating hormone receptor by the transcription factors upstream stimulatory factor 1 and upstream stimulatory factor 2 is cell specific.
Hermann BP; Hornbaker K; Rice DA; Sawadogo M; Heckert LL
Endocrinology; 2008 Oct; 149(10):5297-306. PubMed ID: 18566134
[TBL] [Abstract][Full Text] [Related]
8. Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
Zhang J; Yang JM; Wang HJ; Ru GQ; Fan DM
PLoS One; 2013; 8(1):e52940. PubMed ID: 23308126
[TBL] [Abstract][Full Text] [Related]
9. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
J Surg Oncol; 2002 Nov; 81(3):148-54; disscusion 154. PubMed ID: 12407728
[TBL] [Abstract][Full Text] [Related]
11. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
12. Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.
Matsuda M; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Uneda K; Haku S; Tsurumi-Ikeya Y; Toya Y; Maeshima Y; Yamashita A; Umemura S
J Biol Chem; 2013 Jun; 288(26):19238-49. PubMed ID: 23653383
[TBL] [Abstract][Full Text] [Related]
13. Heparanase mRNA expression and point mutation in hepatocellular carcinoma.
Chen XP; Liu YB; Rui J; Peng SY; Peng CH; Zhou ZY; Shi LH; Shen HW; Xu B
World J Gastroenterol; 2004 Oct; 10(19):2795-9. PubMed ID: 15334672
[TBL] [Abstract][Full Text] [Related]
14. Gene trapping uncovers sex-specific mechanisms for upstream stimulatory factors 1 and 2 in angiotensinogen expression.
Park S; Liu X; Davis DR; Sigmund CD
Hypertension; 2012 Jun; 59(6):1212-9. PubMed ID: 22547438
[TBL] [Abstract][Full Text] [Related]
15. [Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].
Chen X; Ye R; Dai D; Wu Y; Yu Y; Cheng B
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1065-1071. PubMed ID: 32895190
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.
Liu YB; Gao SL; Chen XP; Peng SY; Fang HQ; Wu YL; Peng CH; Tang Z; Xu B; Wang JW; Deng GL; Li HJ; Feng XD; Qian HR
World J Gastroenterol; 2005 Mar; 11(9):1378-81. PubMed ID: 15761980
[TBL] [Abstract][Full Text] [Related]
17. Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis.
Utsunomiya H; Cheng YH; Lin Z; Reierstad S; Yin P; Attar E; Xue Q; Imir G; Thung S; Trukhacheva E; Suzuki T; Sasano H; Kim JJ; Yaegashi N; Bulun SE
Mol Endocrinol; 2008 Apr; 22(4):904-14. PubMed ID: 18165439
[TBL] [Abstract][Full Text] [Related]
18. Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.
Zhao X; Wang T; Liu B; Wu Z; Yu S; Wang T
Tumour Biol; 2015 Apr; 36(4):2551-8. PubMed ID: 25480412
[TBL] [Abstract][Full Text] [Related]
19. Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons.
Park KY; Russo AF
J Biol Chem; 2008 Feb; 283(9):5441-51. PubMed ID: 18167349
[TBL] [Abstract][Full Text] [Related]
20. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
Xu Q; Cai W; Zhang M; Liu Q; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]